Nivolumab-Induced Secondary Sclerosing Cholangitis with Deterioration Despite Immunosuppression

被引：15

作者：

Anderson, Brady ^{[1
]}

Dawe, David E. ^{[1
,2
]}

机构：

[1] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada

[2] CancerCare Manitoba, Dept Med Oncol & Hematol, Winnipeg, MB, Canada

来源：

JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 09期

关键词：

D O I：

10.1016/j.jtho.2019.04.023

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：E205 / E206

页数：3

共 5 条

[1] Nivolumab-induced cholangitic liver disease: a novel form of serious liver injury [J].

Gelsomino, F. ;

Vitale, G. ;

D'Errico, A. ;

Bertuzzi, C. ;

Andreone, P. ;

Ardizzoni, A. .

ANNALS OF ONCOLOGY, 2017, 28 (03) :671-672

[2] Pembrolizumab for the treatment of thoracic malignancies: current landscape and future directions [J].

Karim, Safiya ;

Leighl, Natasha .

FUTURE ONCOLOGY, 2016, 12 (01) :9-23

[3] Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancer [J].

Kawakami, Hisato ;

Tanizaki, Junko ;

Tanaka, Kaoru ;

Haratani, Koji ;

Hayashi, Hidetoshi ;

Takeda, Masayuki ;

Kamata, Ken ;

Takenaka, Mamoru ;

Kimura, Masatomo ;

Chikugo, Takaaki ;

Sato, Takao ;

Kudo, Masatoshi ;

Ito, Akihiko ;

Nakagawa, Kazuhiko .

INVESTIGATIONAL NEW DRUGS, 2017, 35 (04) :529-536

[4] Poor response of initial steroid therapy for IgG4-related sclerosing cholangitis with multiple organs affected [J].

Liu, Wei ;

Chen, Weijie ;

He, Xiaodong ;

Qu, Qiang ;

Hong, Tao ;

Li, Binglu .

MEDICINE, 2017, 96 (12)

[5] Primary Sclerosing Cholangitis: Diagnosis, Prognosis, and Management [J].

Singh, Siddharth ;

Talwalkar, Jayant A. .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (08) :898-907

← 1 →